These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19340528)

  • 21. Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients.
    Trifilio S; Pennick G; Pi J; Zook J; Golf M; Kaniecki K; Singhal S; Williams S; Winter J; Tallman M; Gordon L; Frankfurt O; Evens A; Mehta J
    Cancer; 2007 Apr; 109(8):1532-5. PubMed ID: 17351937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients.
    Rüping MJ; Müller C; Vehreschild JJ; Böhme A; Mousset S; Harnischmacher U; Frommolt P; Wassmer G; Drzisga I; Hallek M; Cornely OA
    Mycoses; 2011 May; 54(3):230-3. PubMed ID: 19889174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
    Lazarus HM; Blumer JL; Yanovich S; Schlamm H; Romero A
    J Clin Pharmacol; 2002 Apr; 42(4):395-402. PubMed ID: 11936564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies.
    Lee YJ; Lee SO; Choi SH; Kim YS; Woo JH; Chun S; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
    Med Mycol; 2013 Apr; 51(3):324-30. PubMed ID: 22712456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical implication of therapeutic drug monitoring on voriconazole from the aspect of the analysis for CYP2C19 gene].
    Kimura M; Yamagishi Y; Kawasumi N; Hagihara M; Hasegawa T; Mikamo H
    Jpn J Antibiot; 2010 Jun; 63(3):255-64. PubMed ID: 20976881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Level of evidence for therapeutic drug monitoring of voriconazole].
    Hulin A; Dailly E; Le Guellec C;
    Therapie; 2011; 66(2):109-14. PubMed ID: 21635857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
    Oyake T; Kowata S; Murai K; Ito S; Akagi T; Kubo K; Sawada K; Ishida Y
    Eur J Haematol; 2016 Jun; 96(6):602-9. PubMed ID: 26216048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].
    Feng AM; Wei JY; Yu WJ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):473-5. PubMed ID: 22213868
    [No Abstract]   [Full Text] [Related]  

  • 29. [Usefulness of monitoring plasma voriconazole concentration in patients with chronic necrotizing pulmonary aspergillosis].
    Hagiwara E; Shiihara J; Matsushima A; Enomoto T; Tagawa A; Sekine A; Tsuchiya N; Baba T; Shinohara T; Endo T; Sogo Y; Nishihira R; Komatsu S; Kato T; Ogura T; Takahashi H
    Nihon Kokyuki Gakkai Zasshi; 2009 Feb; 47(2):93-7. PubMed ID: 19260530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective serological tests for determining the optimal blood concentration of voriconazole for treating fungal infection.
    Okuda T; Okuda A; Watanabe N; Takao M; Takayanagi K
    Yakugaku Zasshi; 2008 Dec; 128(12):1811-8. PubMed ID: 19043301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
    Yilmaz D; Balkan C; Ay Y; Akin M; Karapinar B; Kavakli K
    Mycoses; 2011 May; 54(3):234-42. PubMed ID: 19906090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voriconazole plasma monitoring.
    Pasqualotto AC; Shah M; Wynn R; Denning DW
    Arch Dis Child; 2008 Jul; 93(7):578-81. PubMed ID: 18252755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Voriconazole concentration is inversely correlated with corticosteroid usage in immunocompromised patients.
    Imataki O; Yamaguchi K; Uemura M; Fukuoka N
    Transpl Infect Dis; 2018 Aug; 20(4):e12886. PubMed ID: 29570914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of therapeutic drug monitoring of voriconazole in a pediatric population.
    Brüggemann RJ; van der Linden JW; Verweij PE; Burger DM; Warris A
    Pediatr Infect Dis J; 2011 Jun; 30(6):533-4. PubMed ID: 21127454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age.
    Shima H; Miharu M; Osumi T; Takahashi T; Shimada H
    Pediatr Blood Cancer; 2010 Jul; 54(7):1050-2. PubMed ID: 20146339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy.
    Li H; Li M; Yan J; Gao L; Zhou L; Wang Y; Li Q; Wang J; Chen T; Wang T; Zheng J; Qiang W; Zhang Y; Shi Q
    Basic Clin Pharmacol Toxicol; 2020 Dec; 127(6):495-504. PubMed ID: 32639669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.
    Heng SC; Snell GI; Levvey B; Keating D; Westall GP; Williams TJ; Whitford H; Nation RL; Slavin MA; Morrissey O; Kong DC
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4581-3. PubMed ID: 23817382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic drug monitoring of voriconazole in children.
    Chen J; Chan C; Colantonio D; Seto W
    Ther Drug Monit; 2012 Feb; 34(1):77-84. PubMed ID: 22210097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis.
    Hamada Y; Seto Y; Yago K; Kuroyama M
    J Infect Chemother; 2012 Aug; 18(4):501-7. PubMed ID: 22231601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.